Treatment of Resistant Nephrotic Syndrome With ACTH Gel (ACTHAR)
This study has been completed.
Sponsor:
Columbia University
Collaborator:
Questcor Pharmaceuticals, Inc.
Information provided by (Responsible Party):
Gerald B. Appel, Columbia University
ClinicalTrials.gov Identifier:
NCT01129284
First received: May 21, 2010
Last updated: August 1, 2012
Last verified: August 2012
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Study Completion Date: | September 2011 |
| Primary Completion Date: | September 2011 (Final data collection date for primary outcome measure) |
No publications provided by Columbia University
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):